New Opportunities to Improve Management of Patients with or at High Risk of ASCVD Events

Featuring a faculty of leading experts in the management of atherosclerotic cardiovascular disease (ASCVD), the program utilizes case-based learning.
2.00 available credits
Featuring a faculty of leading experts in the management of atherosclerotic cardiovascular disease (ASCVD), the program utilizes case-based learning.
2.00 available credits
Enroll in this meeting
April 11, 2019
06:30 PM - 09:00 PM EDT
Philadelphia 201 Hotel
201 N. 17th Street, Philadelphia, Pennsylvania, United States
Enrollment Fee: Free
Free
  • Overview

    This timely and engaging CME-certified symposium will offer in-depth coverage of important clinical issues and data. Featuring a faculty of leading experts in the management of atherosclerotic cardiovascular disease (ASCVD), the program will utilize case-based learning in a highly interactive format to optimize clinical strategies.

    Agenda Topics Include

    • Update on Determining Risk Status in ASCVD
    • New Approaches to the Management of Patients at High Risk of CVD Events
    • Managing Residual Risk Beyond LDL-C Lowering Therapy
    • Practical Considerations to Manage Residual Risk
    • Case Simulations on Primary and Secondary Prevention of ASCVD Events
  • Program Schedule*

     

    6:30 pm–7:00 pm             

    Registration & Dinner

     

     

     

     

    7:00 pm–7:10 pm

    Welcome, Introductions, Program Overview, and Pre-Activity Test Questions

     

     

     

     

    7:10 pm–7:25 pm

    Update on Determining Risk Status in ASCVD

     

     

     

     

    7:25 pm–7:30 pm

    Discussion and Question & Answers

     

     

     

     

    7:30 pm–7:45 pm

    New Approaches to the Management of Patients at High-Risk of CVD Events

     

     

     

     

    7:45 pm–7:50 pm

    Discussion and Question & Answers

     

     

     

     

    7:50 pm–8:15 pm

    Managing Residual Risk Beyond LDL-C Lowering Therapy

     

     

     

     

    8:15 pm–8:20 pm

    Discussion and Question & Answers

     

     

     

     

    8:20 pm–8:35 pm

    Practical Considerations to Manage Residual Risk

     

     

     

     

    8:35 pm–8:40 pm

    Discussion and Question & Answers

     

     

     

     

    8:40 pm–8:55 pm

    Case Simulations on Primary and Secondary Prevention of ASCVD Events

     

     

     

     

    8:55 pm–9:00 pm

    Post-activity test questions, Closing Comments, and Adjourn

     

    *Topics subject to change

  • Target Audience

    This course is designed to meet the continuing medical education needs of the Internal Medicine and Primary Care Physicians and allied health professionals who treat patients with, or at high risk of, ASCVD.

  • Providers

    Jointly provided by TOPEC and Medtelligence.

       

  • Commercial Support

    This activity is supported by independent educational grants from Amarin Pharma, Inc.

Facebook Comments

Sign up for the Medtelligence newsletters.
Comprehensive Cardiology Education.

Better education for a better you.

* Required
Optional
Register

We’re glad to see you’re enjoying Medtelligence…
but how about a more personalized experience?

Register for free